HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of primary binding assays for presumptive serodiagnosis of swine brucellosis in Argentina.

Abstract
An indirect enzyme-linked immunosorbent assay (IELISA), a competitive ELISA (CELISA), and a fluorescence polarization assay (FPA) for the presumptive serological diagnosis of swine brucellosis were evaluated using two populations of swine sera: sera from brucellosis-free Canadian herds and sera from Argentina selected based on positive reactions in the buffered antigen plate agglutination test (BPAT) and the 2-mercaptoethanol (2-ME) test. In addition, sera from adult swine from which Brucella suis was isolated at least once for each farm of origin were evaluated. The IELISA, CELISA, and FPA specificity values were 99.9, 99.5, and 98. 3%, respectively, and the IELISA, CELISA, and FPA sensitivity values relative to the BPAT and the 2-ME test were 98.9, 96.6, and 93.8%, respectively. Actual sensitivity was assessed by using 37 sera from individual pigs from which B. suis was cultured, and the values obtained were as follows: BPAT, 86.5%; 2-ME test, 81.1%; IELISA, 86.5%; CELISA, 78.5%; and FPA, 80.0%.
AuthorsP S Paulo, A M Vigliocco, R F Ramondino, D Marticorena, E Bissi, G Briones, C Gorchs, D Gall, K Nielsen
JournalClinical and diagnostic laboratory immunology (Clin Diagn Lab Immunol) Vol. 7 Issue 5 Pg. 828-31 (Sep 2000) ISSN: 1071-412X [Print] United States
PMID10973463 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Animals
  • Argentina
  • Brucella (immunology)
  • Brucellosis (diagnosis, immunology, microbiology, veterinary)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Serologic Tests (methods)
  • Swine
  • Swine Diseases (diagnosis, immunology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: